phenelzine has been researched along with Briquet Syndrome in 3 studies
Phenelzine: One of the MONOAMINE OXIDASE INHIBITORS used to treat DEPRESSION; PHOBIC DISORDERS; and PANIC.
Excerpt | Relevance | Reference |
---|---|---|
"The prognosis of treated hypochondriasis is good in a substantial proportion of patients." | 1.27 | Functional somatic symptoms and hypochondriasis. A survey of empirical studies. ( Kellner, R, 1985) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gorman, JM | 1 |
Kellner, R | 1 |
Davidson, J | 1 |
Pelton, S | 1 |
1 trial available for phenelzine and Briquet Syndrome
Article | Year |
---|---|
Forms of atypical depression and their response to antidepressant drugs.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Anxiety Disorders; Bupropion; Clinical Trial | 1986 |
2 other studies available for phenelzine and Briquet Syndrome
Article | Year |
---|---|
Leading the way: advances in the diagnosis, treatment, and management of neuropsychiatric illnesses.
Topics: Administration, Cutaneous; Administration, Topical; Brain; Depressive Disorder, Major; Humans; Menta | 2006 |
Functional somatic symptoms and hypochondriasis. A survey of empirical studies.
Topics: Anti-Anxiety Agents; Attitude to Health; Benzodiazepines; Conditioning, Psychological; Culture; Diag | 1985 |